Latest Articles

Publication Date
In silico evaluation of procyanidin as a potential ESR1 inhibitor: docking and MD insights in uterine fibroids and endometriosis.

These are two of the most common gynecologic diseases, affecting 15% to 80% of women of childbearing age diseases. The existing treatments, such as hormonal drugs and selective estrogen receptor …

Published: Jan. 14, 2026, midnight
Therapeutic potential of epigallocatechin gallate in gynecologic cancer, endometriosis, polycystic ovary syndrome: a mechanistic and translational perspective.

Tea, among the most widely consumed beverages worldwide, is rich in polyphenolic compounds known as catechins, particularly epigallocatechin gallate (EGCG). This review aims to synthesize recent findings and ongoing controversies …

Published: Jan. 13, 2026, midnight
En Bloc Hysterectomy with segmental bowel resection by NOSE-procedure: Surgical Management of Ovarian Cancer in context of Deep Infiltrating Endometriosis.

To show the safety of en bloc hysterectomy with segmental bowel resection utilizing the NOSE-technique in the management of ovarian cancer and deep infiltrating endometriosis (DIE).

Published: Jan. 12, 2026, midnight
Comparative safety profiles of spironolactone, eplerenone, and finerenone: a pharmacovigilance study based on FAERS data from 2004 to 2024.

Spironolactone, eplerenone, and finerenone are three commonly used mineralocorticoid receptor antagonists (MRAs) with cardioprotective and renoprotective effects. However, comparative real-world safety evaluations remain limited. This study aimed to assess and …

Published: Jan. 7, 2026, midnight
Terumo launches SurTract Safety Syringe in U.S. - Med-Tech Insights

Terumo launches SurTract Safety Syringe in U.S. Med-Tech Insights

Published: Jan. 6, 2026, 4:18 p.m.
First live births after adipose-derived stem cells and platelet-rich plasma intraovarian administration.

This report describes two women aged 45 and older who achieved live births following intraovarian administration of a novel combination of mechanically processed adipose nanofat rich in adipose-derived stem cells …

Published: Dec. 25, 2025, midnight
Correction to: Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.

Published: Dec. 24, 2025, midnight
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology

Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology

Published: Dec. 22, 2025, 1:15 p.m.
Dow Update: What dividend safety score for REPX stock - 2025 Risk Factors & Free Expert Verified Stock Movement Alerts - moha.gov.vn

Dow Update: What dividend safety score for REPX stock - 2025 Risk Factors & Free Expert Verified Stock Movement Alerts moha.gov.vn

Published: Dec. 21, 2025, 8:03 a.m.
Ultrasonic surgical aspiration (CUSA®) for laparoscopic excision of endometriosis: a prospective case series demonstrating safety and precision in fertility-preserving surgery.

Endometriosis affects ∼10% of women of reproductive age, often causing chronic pelvic pain and infertility. Conventional energy devices risk thermal injury and bleeding, particularly in fertility-preserving surgeries. The Cavitron Ultrasonic …

Published: Dec. 16, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!